Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 4.852\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] CCCn1c2c(c(O)c(C(=O)Nc3ccccc3)c1=O)CCCC2
[b] CCC1(CC)NC(=O)N(CC(=O)OCC(=O)Nc2ccc(F)c(F)c2F)C1=O
Answer: b. CCC1(CC)NC(=O)N(CC(=O)OCC(=O)Nc2ccc(F)c(F)c2F)C1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC1(CC)NC(=O)N(CC(=O)OCC(=O)Nc2ccc(F)c(F)c2F)C1=O
CCC1(CC)NC(=O)N(CC(=O)OCC(=O)Nc2ccc(F)c(F)c2F)C1=O
[2-oxo-2-(2,3,4-trifluoroanilino)ethyl] 2-(4,4-diethyl-2,5-dioxoimidazolidin-1-yl)acetate